These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9246238)
1. Glycosphingolipid antigens from Leishmania (L.) amazonensis amastigotes. Binding of anti-glycosphingolipid monoclonal antibodies in vitro and in vivo. Straus AH; Valero VB; Takizawa CM; Levery SB; Toledo MS; Suzuki E; Salyan ME; Hakomori S; Barbieri CL; Takahashi HK Braz J Med Biol Res; 1997 Mar; 30(3):395-9. PubMed ID: 9246238 [TBL] [Abstract][Full Text] [Related]
2. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. Straus AH; Levery SB; Jasiulionis MG; Salyan ME; Steele SJ; Travassos LR; Hakomori S; Takahashi HK J Biol Chem; 1993 Jun; 268(18):13723-30. PubMed ID: 8514804 [TBL] [Abstract][Full Text] [Related]
3. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody. Barbiéri CL; Giorgio S; Merjan AJ; Figueiredo EN Infect Immun; 1993 May; 61(5):2131-7. PubMed ID: 7683002 [TBL] [Abstract][Full Text] [Related]
4. Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity. Tanaka AK; Gorin PA; Takahashi HK; Straus AH Braz J Med Biol Res; 2007 Jun; 40(6):799-806. PubMed ID: 17581678 [TBL] [Abstract][Full Text] [Related]
5. Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid. Winter G; Fuchs M; McConville MJ; Stierhof YD; Overath P J Cell Sci; 1994 Sep; 107 ( Pt 9)():2471-82. PubMed ID: 7844164 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. Pan AA; McMahon-Pratt D J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920 [TBL] [Abstract][Full Text] [Related]
7. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms. Hodgkinson VH; Soong L; Duboise SM; McMahon-Pratt D Exp Parasitol; 1996 Jun; 83(1):94-105. PubMed ID: 8654556 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A; Bates PA; Chance ML; Taylor MJ Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391 [TBL] [Abstract][Full Text] [Related]
10. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis. Hernández-Chinea C Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum. Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507 [TBL] [Abstract][Full Text] [Related]
12. [Production of monoclonal antibodies against Leishmania mexicana mexicana antigens]. Correnti M; Ortega G Acta Cient Venez; 1991; 42(4):226-8. PubMed ID: 1843566 [TBL] [Abstract][Full Text] [Related]
13. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. De Souza Leao S; Lang T; Prina E; Hellio R; Antoine JC J Cell Sci; 1995 Oct; 108 ( Pt 10)():3219-31. PubMed ID: 7593283 [TBL] [Abstract][Full Text] [Related]
14. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway. Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746 [TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface. Wolfram M; Fuchs M; Wiese M; Stierhof YD; Overath P Eur J Immunol; 1996 Dec; 26(12):3153-62. PubMed ID: 8977317 [TBL] [Abstract][Full Text] [Related]
16. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate. Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice. Pratti JE; Ramos TD; Pereira JC; da Fonseca-Martins AM; Maciel-Oliveira D; Oliveira-Silva G; de Mello MF; Chaves SP; Gomes DC; Diaz BL; Rossi-Bergmann B; de Matos Guedes HL Parasit Vectors; 2016 Oct; 9(1):534. PubMed ID: 27716449 [TBL] [Abstract][Full Text] [Related]
18. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis]. Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193 [TBL] [Abstract][Full Text] [Related]
19. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Beyrodt CG; Pinto AR; Freymüller E; Barbiéri CL Infect Immun; 1997 Jun; 65(6):2052-9. PubMed ID: 9169731 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana. Dissanayake S; Shahin A; Ameen AM Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]